Volume 10, Issue 3 (Vol.10 No.3 Oct 2021)
rbmb.net 2021, 10(3): 387-395 |
Back to browse issues page
Seyed Mojtaba Mortazavi 
, Amin Tarinjoo , Sepideh Dastani , Majid Niazpour , Samira Dahaghin * , Reza Mirnejad*
, Amin Tarinjoo , Sepideh Dastani , Majid Niazpour , Samira Dahaghin * , Reza Mirnejad*
Department of Microbiology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Abstract: (3371 Views)
Background: According to the studies, many pathogens function as cofactors interacting with Human papillomavirus in the development of pre-cancer or cancer of the cervix. The aim of this study was to investigate the prevalence rate of Sexually Transmitted Infections (STIs) pathogens including Mycoplasma hominis, Ureaplasma urealyticum, Chlamydia trachomatis, Neisseria gonorrhoeae, Gardnerella vaginalis, and Streptococcus agalactiae in people with HPV and without HPV infection, and frequency rate of these pathogens in high and low risk of HPV.
Methods: Cervical samples of 280 women who referred to Tehran west hospitals in Iran, between 2019 and 2020, were collected. After DNA extraction of samples, identification of HPV and genotyping was performed, and then, to detect each microorganism, the PCR was carried out with specific primers. Finally, the results were analyzed using descriptive statistics tests.
Results: The mean age of patients was 37 years. Two groups of patients were identified based on positivity or negativity of HPV. In HPV-positive group (118 cases), the prevalence of U. urealyticum, M. hominis, N. gonorrhoeae, G. vaginalis, and S. agalactiae was 38 (13%), 7 (62%), 5.93%, 19.49%, 0.84% respectively. In HPV-negative group (162 cases), rate of infection with U. urealyticum, M. hominis, N. gonorrhoeae, G. vaginalis, and S. agalactiae was 29.62%, 6.17%, 3.08%, 16.04%, 0.61% respectively. Among the two groups, there was only 1 patient with C. trachomatis (0.84%), seen in HPV-positive group.
Conclusions: In this study no significant association was found between HPV and bacteria such as G. vaginalis and S. agalactiae, and it was found that C. trachomatis, and especially N. gonorrhoeae are strongly associated with HPV infection.
Methods: Cervical samples of 280 women who referred to Tehran west hospitals in Iran, between 2019 and 2020, were collected. After DNA extraction of samples, identification of HPV and genotyping was performed, and then, to detect each microorganism, the PCR was carried out with specific primers. Finally, the results were analyzed using descriptive statistics tests.
Results: The mean age of patients was 37 years. Two groups of patients were identified based on positivity or negativity of HPV. In HPV-positive group (118 cases), the prevalence of U. urealyticum, M. hominis, N. gonorrhoeae, G. vaginalis, and S. agalactiae was 38 (13%), 7 (62%), 5.93%, 19.49%, 0.84% respectively. In HPV-negative group (162 cases), rate of infection with U. urealyticum, M. hominis, N. gonorrhoeae, G. vaginalis, and S. agalactiae was 29.62%, 6.17%, 3.08%, 16.04%, 0.61% respectively. Among the two groups, there was only 1 patient with C. trachomatis (0.84%), seen in HPV-positive group.
Conclusions: In this study no significant association was found between HPV and bacteria such as G. vaginalis and S. agalactiae, and it was found that C. trachomatis, and especially N. gonorrhoeae are strongly associated with HPV infection.
Type of Article: Original Article |
Subject:
Microbiology
Received: 2020/11/15 | Accepted: 2020/12/13 | Published: 2021/12/5
Received: 2020/11/15 | Accepted: 2020/12/13 | Published: 2021/12/5
References
1. Stanley MA, Pett MR, Coleman N. HPV: from infection to cancer. Biochem Soc Trans. 2007;35(Pt 6):1456-60. [DOI:10.1042/BST0351456] [PMID]
2. Houlihan CF, Larke NL, Watson-Jones D, Smith-McCune KK, Shiboski S, Gravitt PE, et al. HPV infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS. 2012;26(17). [DOI:10.1097/QAD.0b013e328358d908] [PMID] [PMCID]
3. Lu H, Jiang P-C, Zhang X-D, Hou W-J, Wei Z-H, Lu J-Q, et al. Characteristics of bacterial vaginosis infection in cervical lesions with high risk human papillomavirus infection. Int J Clin Exp Med. 2015;8(11):21080-21088.
4. Lee JE, Lee S, Lee H, Song Y-M, Lee K, Han MJ, et al. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PloS one. 2013;8(5):e63514. [DOI:10.1371/journal.pone.0063514] [PMID] [PMCID]
5. Nardis C, Mosca L, Mastromarino P. Vaginal microbiota and viral sexually transmitted diseases. Ann Ig. 2013;25(5):443-56.
6. Gallo MF, Macaluso M, Warner L, Fleenor ME, Hook III EW, Brill I, et al. Bacterial vaginosis, gonorrhea, and chlamydial infection among women attending a sexually transmitted disease clinic: a longitudinal analysis of possible causal links. Ann Epidemiol. 2012;22(3):213-20. [DOI:10.1016/j.annepidem.2011.11.005] [PMID]
7. Panchaud C, Singh S, Feivelson D, Darroch JE. Sexually transmitted diseases among adolescents in developed countries. Fam Plann Perspect. 2000;32(1):24-32. [DOI:10.2307/2648145] [PMID]
8. Horner P, Donders G, Cusini M, Gomberg M, Jensen J, Unemo M. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women?-a position statement from the European STI Guidelines Editorial Board. J Eur Acad Dermatol Venereol. 2018;32(11):1845-1851. [DOI:10.1111/jdv.15146] [PMID]
9. Lukic A, Canzio C, Patella A, Giovagnoli M, Cipriani P, Frega A, et al. Determination of cervicovaginal microorganisms in women with abnormal cervical cytology: the role of Ureaplasma urealyticum. Anticancer Res. 2006;26(6C):4843-9.
10. Biernat-Sudolska M, Szostek S, Rojek-Zakrzewska D, Klimek M, Kosz-Vnenchak M. Concomitant infections with human papillomavirus and various mycoplasma and ureaplsasma species in women with abnormal cervical cytology. Adv Med Sci. 2011;56(2):299-303. [DOI:10.2478/v10039-011-0028-9] [PMID]
11. Mousavi A, Farhadifar F, Mirnejad R, Ramazanzadeh R. Detection of genital mycoplasmal infections among infertile females by multiplex PCR. Iran J Microbiol. 2014;6(6):398-403.
12. Najar Peerayeh S, Samimi R. Detection of ureaplasma urealyticum in clinical samples from infertile women by polymerase chain reaction. Iranian Journal of Pharmacology and Therapeutics. 2007;6(1):23-26.
13. Hartmann M. Genital mycoplasmas. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2009;7(4):371-7.
https://doi.org/10.1111/j.1610-0387.2008.06965_supp.x [DOI:10.1111/j.1610-0387.2008.06965.x] [PMID]
14. O'Connell CM, Ferone ME. Chlamydia trachomatis genital infections. Microb Cell. 2016;3(9):390-403. [DOI:10.15698/mic2016.09.525] [PMID] [PMCID]
15. Whiley DM, Tapsall JW, Sloots TP. Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge. J Mol Diagn. 2006;8(1):3-15. [DOI:10.2353/jmoldx.2006.050045] [PMID] [PMCID]
16. Rostami MN, Rashidi BH, Habibi A, Nazari R, Dolati M. Genital infections and reproductive complications associated with Trichomonas vaginalis, Neisseria gonorrhoeae, and Streptococcus agalactiae in women of Qom, central Iran. Int J Reprod Biomed. 2017;15(6):357-366. [DOI:10.29252/ijrm.15.6.357]
17. Edwards MS, Baker CJ. Streptococcus Agalactiae (group B streptococcus). Mandel GL, Bennett JE, Dolin R eds. Principles and Practice of Infectious Diseases 4th ed. New York: Churchill Livingston Inc. 1995:1835-1845.
18. Catlin BW. Gardnerella vaginalis: characteristics, clinical considerations, and controversies. Clin Microbiol Rev. 1992;5(3):213-37. [DOI:10.1128/CMR.5.3.213] [PMID] [PMCID]
19. Amaya RA, Al-Dossary F, Demmler GJ. Gardnerella vaginalis bacteremia in a premature neonate. J Perinatol. 2002;22(7):585-7. [DOI:10.1038/sj.jp.7210757] [PMID]
20. Papp JR, Schachter J, Gaydos CA, Van Der Pol B. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae-2014. MMWR Recomm Rep. 2014;63(RR-02):1-19.
21. Teng K, Li M, Yu W, Li H, Shen D, Liu D. Comparison of PCR with culture for detection of Ureaplasma urealyticum in clinical samples from patients with urogenital infections. J Clin Microbiol. 1994;32(9):2232-4. [DOI:10.1128/jcm.32.9.2232-2234.1994] [PMID] [PMCID]
22. Finan R, Tamim H, Almawi W. Identification of Chlamydia trachomatis DNA in human papillomavirus (HPV) positive women with normal and abnormal cytology. Archives of gynecology and obstetrics. 2002;266(3):168-71. [DOI:10.1007/s00404-001-0261-8] [PMID]
23. Mirnejad R, Amirmozafari N, Kazemi B. Simultaneous and rapid differential diagnosis of Mycoplasma genitalium and Ureaplasma urealyticum based on a polymerase chain reaction-restriction fragment length polymorphism. Indian J Med Microbiol. 2011;29(1):33-6. [DOI:10.4103/0255-0857.76521] [PMID]
24. Ataee RA, Golmohammadi R, Alishiri GH, Mirnejad R, Najafi A, Esmaeili D, et al. Simultaneous Detection of Mycoplasma pneumoniae, Mycoplasma hominis and Mycoplasma arthritidis in Synovial Fluid of Patients with Rheumatoid Arthritis by Multiplex PCR. Arch Iran Med. 2015;18(6):345-50.
25. Hajikhani B, Motallebi T, Norouzi J, Bahador A, Bagheri R, Asgari S, et al. Classical and molecular methods for evaluation of Chlamydia trachomatis infection in women with tubal factor infertility. J Reprod Infertil. 2013;14(1):29-33.
26. Karimpour A, Esmaeelnezhad Moghadam A, Moslemizadeh N, Mousanezhad N, Peyvandi S, Gahandar M. Incidence and main causes of infertility in patients attending the infertility center of Imam khomeini hospital in 2002-2004. Journal of Mazandaran University of Medical Sciences. 2005;15(49):44-9.
27. Malaguti N, Bahls LD, Uchimura NS, Gimenes F, Consolaro MEL. Sensitive detection of thirteen bacterial vaginosis-associated agents using multiplex polymerase chain reaction. BioMed research international. 2015;2015. [DOI:10.1155/2015/645853] [PMID] [PMCID]
28. Fouad M, Zakaria S, Metwally L, Aboul-Atta H, Kamel M. Detection of Maternal Colonization of Group B Streptococcus by PCR Targeting cfb and scpB Genes. Journal of Microbiology, Biotechnology and Food Sciences. 2016;6(1):713. [DOI:10.15414/jmbfs.2016.6.1.713-716]
29. Murta EFC, Souza MAHd, Araújo Júnior E, Adad SJ. Incidence of Gardnerella vaginalis, Candida sp and human papilloma virus in cytological smears. Sao Paulo Med J. 2000;118(4):105-8. [DOI:10.1590/S1516-31802000000400006] [PMID]
30. Lugo LZ, Jacob C, Machado AP, Almeida FG, Ávila LS, Prata T, et al. Human papillomavirus and coinfections with Chlamydia trachomatis, Gardnerella vaginalis, and Trichomonas vaginalis in self-collected samples from female sex workers in the Central-Western region of Brazil. Jornal Brasileiro de Patologia e Medicina Laboratorial. 2018;54(1):46-51. [DOI:10.5935/1676-2444.20180010]
31. Martinelli M, Musumeci R, Sechi I, Sotgiu G, Piana A, Perdoni F, et al. Prevalence of Human Papillomavirus (HPV) and Other Sexually Transmitted Infections (STIs) among Italian Women Referred for a Colposcopy. Int J Environ Res Public Health. 2019;16(24):5000. [DOI:10.3390/ijerph16245000] [PMID] [PMCID]
32. Ekiel A, Pietrzak B, Wiechuła B, Aptekorz M, Mazanowska N, Rady D, et al. Urogenital mycoplasmas and human papilloma virus in hemodialysed women. The Scientific World Journal. 2013;2013:(4);659204. [DOI:10.1155/2013/659204] [PMID] [PMCID]
33. Del Prete R, Ronga L, Lestingi M, Addati G, Angelotti UF, Di Carlo D, et al. Simultaneous detection and identification of STI pathogens by multiplex Real-Time PCR in genital tract specimens in a selected area of Apulia, a region of Southern Italy. Infection. 2017;45(4):469-477. [DOI:10.1007/s15010-017-1002-7] [PMID]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |